- Learn the basics
- Find stocks
- Understand a stock
Abpro Holdings, Inc.
ABPWW United States OTCAbpro Holdings, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of antibody-based therapeutics. The Company applies its proprietary DiversImmune and MultiMab platforms to generate monoclonal and multispecific antibodies intended for use in human therapeutics. The Company operates in a single business segment focused on research, development, and preclinical and clinical advancement of biologic product candidates. Its pipeline targets oncology indications, including HER2-positive solid tumors, with lead candidates designed as bispecific constructs. Development activities address the global market for antibody therapeutics used in the treatment of cancer and other serious diseases.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company and how factual it is. What the ratings mean.